Operation of the Company’s Business. During the Pre-Closing Period, except (x) as expressly required by this Agreement or as required by applicable Legal Requirements, (y) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) as set forth in Section 5.2 of the Company Disclosure Schedule:
Appears in 5 contracts
Samples: Agreement and Plan of Merger (Kite Pharma, Inc.), Agreement and Plan of Merger (Allergan PLC), Agreement and Plan of Merger (Stemline Therapeutics Inc)
Operation of the Company’s Business. (a) During the Pre-Closing Period, except to the extent Parent shall otherwise consent in writing (xsuch consent not to be unreasonably withheld or delayed) and except as expressly required by this Agreement or as required by applicable Legal Requirements, (y) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) as set forth in Section 5.2 of the Company Disclosure ScheduleAgreement:
Appears in 4 contracts
Samples: Agreement and Plan of Merger (Netratings Inc), Agreement and Plan of Merger (Netratings Inc), Agreement and Plan of Merger (Netratings Inc)
Operation of the Company’s Business. During the Pre-Closing Period, except (x) as expressly required by this Agreement or as required by applicable Legal RequirementsRequirements or to the extent necessary to comply with any obligation under any Contracts made available to Parent on or prior to the date of this Agreement, (y) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) as set forth in Section 5.2 of the Company Disclosure Schedule:
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Gilead Sciences Inc), Agreement and Plan of Merger (Forty Seven, Inc.)
Operation of the Company’s Business. During the Pre-Closing Period, except (x) as expressly required by this Agreement or as required by applicable Legal Requirements, (y) with the written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (z) as set forth in Section 5.2 of the Company Disclosure Schedule:
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Cti Biopharma Corp), Agreement and Plan of Merger (Cti Biopharma Corp)
Operation of the Company’s Business. (a) During the Pre-Closing Period, except as (xw) as expressly required by this Agreement or as required by applicable Legal RequirementsRequirements or Orders, (x) expressly permitted by the terms of this Section 5.2, or (y) with set forth in Part 5.2 of the written consent of Company Disclosure Schedule or (z) consented to by Parent (which consent shall consent, as to subsection (ii) hereof, will not be unreasonably withheld, conditioned or delayed), or (z) as set forth in Section 5.2 of the Company Disclosure Schedule:):
Appears in 1 contract
